CytoSorbents Corp (CTSO)

Add to Watchlists
Create an Alert
4.79 +0.12  +2.57% NASDAQ Oct 22, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/06/2019 16:45 EST Misc CytoSorbents Corp Third Quarter Earnings Conference Call in 2019
11/06/2019 Earnings CytoSorbents Corp Third Quarter Earnings in 2019 Release
08/06/2019 16:45 EDT Misc CytoSorbents Corp Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings CytoSorbents Corp Second Quarter Earnings in 2019 Release
06/04/2019 10:00 EDT Misc CytoSorbents Corp Annual General Meeting in 2018
05/07/2019 16:45 EDT Misc CytoSorbents Corp First Quarter Earnings Conference Call in 2019
05/07/2019 Earnings CytoSorbents Corp First Quarter Earnings in 2019 Release
03/07/2019 16:45 EST Misc CytoSorbents Corp Fourth Quarter Earnings Conference Call in 2018
03/07/2019 Earnings CytoSorbents Corp Fourth Quarter Earnings in 2018 Release
03/07/2019 Misc CytoSorbents Corp Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.cytosorbents.com
  • Investor Relations URL: http://cytosorbents.com/investor-relations/overview/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 06, 2019
  • Last Earnings Release: Aug. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries.The Company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend, K ontrol, and DrugSorb. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.